CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gottlieb, E.
Right arrow Articles by Oren, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gottlieb, E.
Right arrow Articles by Oren, M.

Cell Growth & Differentiation, Vol 7, Issue 3 301-310, Copyright © 1996 by American Association of Cancer Research


ARTICLES

Relationship of sequence-specific transactivation and p53-regulated apoptosis in interleukin 3-dependent hematopoietic cells

E Gottlieb, S Lindner and M Oren
Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.

The p53 tumor suppressor has been implicated in the control of apoptosis in response to various signals, including DNA damage, oncogene activation, and survival factor withdrawal. The p53 protein is a transcription factor capable of sequence-specific transactivation of target genes. The relationship between p53-mediated transactivation and apoptosis was probed in interleukin 3 (IL-3)-dependent DA-1 lymphoma cells. DA-1 cells express endogenous wild-type p53, which is required for the efficient induction of apoptosis by IL-3 deprivation. IL-3 withdrawal caused no detectable increase in p53 and no concomitant activation of p53-responsive promoters. Conversely, high levels of transfected, transcriptionally active p53 did not elicit any apoptosis as long as IL-3 was present; instead, the cells underwent a viable G1 arrest. IL-3 protected DA-1 cells from the apoptotic effect of low doses of radiation. However, higher doses triggered p53-dependent apoptosis, even in the presence of IL-3. Irrespective of their different effects on viability, sublethal and lethal radiation caused a comparable augmentation of p53-dependent transactivation. Lethal radiation induced an initial p53-dependent G1 arrest, but subsequent apoptosis was preceded by cell cycle re-entry. Our data support the conjecture that activities of p53 distinct from specific transcriptional activation may contribute to apoptosis, although activation of genes such as Bax is also likely to play a role.


This article has been cited by other articles:


Home page
J Biol ChemHome page
Y. Zhao, J. L. Coloff, E. C. Ferguson, S. R. Jacobs, K. Cui, and J. C. Rathmell
Glucose Metabolism Attenuates p53 and Puma-dependent Cell Death upon Growth Factor Deprivation
J. Biol. Chem., December 26, 2008; 283(52): 36344 - 36353.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. W. Goetz, H. van der Kuip, R. Maya, M. Oren, and W. E. Aulitzky
Requirement for Mdm2 in the Survival Effects of Bcr-Abl and Interleukin 3 in Hematopoietic Cells
Cancer Res., October 1, 2001; 61(20): 7635 - 7641.
[Abstract] [Full Text] [PDF]


Home page
The OncologistHome page
A. Di Bacco, K. Keeshan, S. L. McKenna, and T. G. Cotter
Molecular Abnormalities in Chronic Myeloid Leukemia: Deregulation of Cell Growth and Apoptosis
Oncologist, October 1, 2000; 5(5): 405 - 415.
[Abstract] [Full Text]


Home page
EMBO J.Home page
E. Gottlieb and M. Oren
p53 facilitates pRb cleavage in IL-3-deprived cells: novel pro-apoptotic activity of p53
EMBO J., July 1, 1998; 17(13): 3587 - 3596.
[Abstract] [Full Text] [PDF]


Home page
EMBO J.Home page
E. Gottlieb, R. Haffner, A. King, G. Asher, P. Gruss, P. Lonai, and M. Oren
Transgenic mouse model for studying the transcriptional activity of the p53 protein: age- and tissue-dependent changes in radiation-induced activation during embryogenesis
EMBO J., March 15, 1997; 16(6): 1381 - 1390.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
X Chen, L J Ko, L Jayaraman, and C Prives
p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells.
Genes & Dev., October 1, 1996; 10(19): 2438 - 2451.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1996 by the American Association of Cancer Research.